RESUMO
In Belgium, nursing homes (NH) were disproportionately affected by the SARS-CoV-2 pandemic. The objective of this study was to compare the risk of SARS-CoV-2 infection in vaccinated and unvaccinated staff members. METHODS: This was a prospective cohort study conducted between February 1 and April 02, 2021, in 99 nursing homes (NHs) in the Walloon Region, a few weeks after the start of the vaccination campaign. A mixed-effects logistic regression analysis was performed to assess the relationship between COVID results of molecular tests on saliva samples of the NHs' staff and their vaccination status. RESULTS: Only 32 (0,1 %) of 39 267 saliva tests were positive. Logistic analysis showed that unvaccinated nursing home staff were 4 times more likely to develop COVID-19 than vaccinated staff during the study period. CONCLUSION: This study demonstrated an early decreased risk of infection in vaccinated NHs staff. Saliva tests were designed to be convenient, less expensive and non-invasive, and could be considered as an alternative to nasopharyngeal tests.
En Belgique, les maisons de repos ont été touchées de manière disproportionnée par la pandémie de SARS-CoV-2. L'objectif de cette étude était de comparer le risque d'infection par le SARS-CoV-2 chez les membres du personnel vaccinés et non vaccinés. Méthodes : Il s'agit d'une étude de cohorte prospective qui s'est déroulée entre le 1er février et le 02 avril 2021 dans 99 maisons de repos (MR) en Région wallonne, quelques semaines après le début de la campagne de vaccination. Une analyse de régression logistique à effets mixtes a été effectuée pour évaluer la relation entre les résultats COVID des tests moléculaires sur des échantillons de salive du personnel des maisons de repos et leur statut vaccinal. Résultats : Seuls 32 (0,1 %) des 39.267 tests salivaires étaient positifs. L'analyse logistique montre que le personnel des maisons de repos non vacciné était 4 fois plus susceptible de développer la COVID-19 que le personnel vacciné pendant la période d'étude. Conclusion : cette étude a mis en évidence une réduction précoce du risque d'infection chez le personnel vacciné des maisons de repos. Les tests salivaires ont été conçus pour être pratiques, moins coûteux et non invasifs, ils pourraient être considérés comme une alternative aux tests nasopharyngés.
Assuntos
COVID-19 , Humanos , Estudos Prospectivos , COVID-19/epidemiologia , COVID-19/prevenção & controle , SARS-CoV-2 , Casas de Saúde , VacinaçãoRESUMO
ETHNOPHARMACOLOGICAL RELEVANCE: Launaea arborescens, its vernacular name is Mol-albina belonging to asteracaea family origin of the southwest of Algeria. This plant is used in folk medicines to treat gastroenteritis, diabetes, child aliment and other diseases; it is taken macerated or boiled. AIM: This study aims to evaluate the anti-inflammation an analgesic activity of the aqueous extract of Launaea arborescens (AqELA) and its pathway of action. METHODS: the investigation of anti-inflammatory and analgesic effects were done using formalin test, acetic acid test. For mechanism investigation, it was used hot plate test to induce opioid receptors, a histamine and serotonin test to induce edema paw, finally, for the TRPV1 receptor, it was used the capsaicin test. RESULTS: The aqueous extract of Launaea arborescens showed a significant inhibition of abdominal writhing test 95% and 100% inhibition of licking paw using acid acetic test and formalin test respectively (EC: 47 mg/kg and 104 mg/kg). The analgesic effect of the aqueous extract of Launaea arborescens showed inhibition of sensation of pain after 120 min compared to morphine effect. The aqueous extract of Launaea arborescens reduced paw volume after 180 min and 120 min for histamine and serotonin respectively with dose-dependent. Concerning of TRPV1 receptors, the inhibition was showed at doses 100 mg and 300 mg. CONCLUSION: Our results contribute towards validation of the traditional use of Launaea arborescens for inflammation ailment.
